MRK News
Merck & Co., Inc.
$147.37
+$5.39(+3.80%)
67
Overall
80
Value
60
Tech
63
Quality
Market Cap
$350.29B
Volume
9.79M
52W Range
$82.01 - $156.92
Target Price
$158.74
MRK news: the latest Merck & Co., Inc. headlines, press releases and market updates, newest first.
Latest MRK News
- UBS Reaffirms Their Buy Rating on Vivmark Residential (VMRK)TipRanks Auto-Generated Intelligence Newsdesk · Oct 14, 2026
- Merck appoints Paul Diaz to its board of directorsTipRanks Auto-Generated Newsdesk · Oct 13, 2026
- Vivmark Residential (VMRK) Gets a Hold from Piper SandlerTipRanks Auto-Generated Intelligence Newsdesk · Oct 12, 2026
- Piper Sandler Sticks to Its Buy Rating for Newmark Group (NMRK)TipRanks Auto-Generated Intelligence Newsdesk · Oct 12, 2026
- Morgan Stanley Reaffirms Their Buy Rating on Vivmark Residential (VMRK)TipRanks Auto-Generated Intelligence Newsdesk · Oct 11, 2026
- 3 ETFs With At Least 13% Upside Potential, According to the AI AnalystSirisha Bhogaraju · Oct 10, 2026
- Moderna Stock (MRNA) Climbs 13% to Top Its 52-Week High — Here’s WhySolomon Oladipupo · Oct 9, 2026
- AI Predicted Novartis’ $30 Billion Drug Failure. Are Biogen and Takeda Next?Ran Melamed · Oct 7, 2026
- RBC Capital Keeps Their Hold Rating on Merck & Company (MRK)TipRanks Auto-Generated Intelligence Newsdesk · Oct 1, 2026
- Wall Street Analysts Are Bullish on Top Healthcare PicksTipRanks Newsroom · Sep 29, 2026
- Citi Remains a Hold on Merck & Company (MRK)TipRanks Auto-Generated Intelligence Newsdesk · Sep 29, 2026
- Analysts Offer Insights on Healthcare Companies: Prime Medicine, Inc. (PRME) and Merck & Company (MRK)TipRanks Newsroom · Sep 25, 2026
- RBC Capital Keeps Their Hold Rating on Merck & Company (MRK)TipRanks Auto-Generated Intelligence Newsdesk · Sep 24, 2026
- Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK), Celldex (CLDX) and Inventiva (IVA)TipRanks Newsroom · Sep 23, 2026
- Wall Street Analysts Are Neutral on Top Healthcare PicksTipRanks Newsroom · Sep 22, 2026
- Why Is Moderna Stock (MRNA) Soaring Today, September 21?Solomon Oladipupo · Sep 21, 2026
- Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK), Envista Holdings (NVST) and Ultragenyx Pharmaceutical (RARE)TipRanks Newsroom · Sep 21, 2026
- 3 ETFs That Could Deliver 10%+ Returns, According to the AI AnalystSirisha Bhogaraju · Sep 19, 2026
- Vivmark Residential Expands Commercial Paper Program CapacityTipRanks Auto-Generated Newsdesk · Sep 17, 2026
- Vivmark Residential updates outlook, highlights post-merger momentumTipRanks Auto-Generated Newsdesk · Sep 16, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MRK | $147.37 | +3.8% | 9.79M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |